Literature DB >> 2977310

In vitro study of expression of interleukin-2 receptors in T-lymphocytes from patients with IgA nephropathy.

K N Lai1, J C Leung, F M Lai.   

Abstract

The present study was undertaken to examine the expression of interleukin-2 receptor (IL-2R)/CD25 antigen in cultured T-lymphocyte subsets in IgA nephropathy. Twenty-four IgA nephritic patients, 12 patients with chronic glomerulonephritis (non-IgA nephropathy), and 17 healthy controls were studied in an infection-free interval. T-cell subsets in peripheral blood mononuclear cells (PBMC) and activated T-lymphocyte subsets expressing IL-2R were determined by double immunofluorescence staining with fluorochromes conjugated to monoclonal antibodies against T-helper/inducer (CD4+) cell, T-suppressor/cytotoxic (CD8+) cell, B (CD20+) lymphocytes, and IL-2R. The percentages of CD4+ and CD8+ lymphocytes, CD4/CD8 ratio, and total activated lymphocytes (with IL-2R/CD25 antigen) did not differ between the IgA nephritic patients, patients with chronic glomerulonephritis, and healthy controls in freshly isolated, unstimulated lymphocytes or PBMC cultured with pokeweed mitogen. Following pokeweed mitogen stimulation for 5 days, 17.3 +/- 10.3%, 16.6 +/- 8.4%, and 16.7 +/- 9.4% of PBMC from IgA nephritic patients, patients with chronic glomerulonephritis, and controls respectively expressed IL-2R (p greater than 0.05). However, the individual T-cell subsets bearing IL-2R were distinctly different between the IgA nephritic patients and patients with chronic glomerulonephritis or healthy controls. IgA nephritic patients had increased activated CD4+ lymphocytes (with IL-2R) (p less than 0.025) and reduced activated CD8+ lymphocytes (p less than 0.025). Our study suggests a defective immunoregulation in IgA nephropathy with enhanced T-helper/inducer and reduced T-suppressor/cytotoxic activity when stimulated with mitogen and probably, during clinical exacerbation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2977310

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  6 in total

1.  T-lymphocyte activation in IgA nephropathy: serum-soluble interleukin 2 receptor level, interleukin 2 production, and interleukin 2 receptor expression by cultured lymphocytes.

Authors:  K N Lai; J C Leung; F M Lai; J S Tam
Journal:  J Clin Immunol       Date:  1989-11       Impact factor: 8.317

2.  T-cell subsets, interleukin-2 receptor expression and production of interleukin-2 in minimal change nephrotic syndrome.

Authors:  R Topaloğlu; U Saatçi; M Arikan; H Canpinar; A Bakkaloğlu; E Kansu
Journal:  Pediatr Nephrol       Date:  1994-12       Impact factor: 3.714

3.  Light-chain ratio of serum IgA1 in IgA nephropathy.

Authors:  S H Chui; C W Lam; W H Lewis; K N Lai
Journal:  J Clin Immunol       Date:  1991-07       Impact factor: 8.317

4.  Cytokine production by peripheral blood mononuclear cells in IgA nephropathy.

Authors:  K N Lai; J C Leung; P K Li; S F Lui
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

5.  Increase of both circulating Th1 and Th2 T lymphocyte subsets in IgA nephropathy.

Authors:  K N Lai; R T Ho; C K Lai; C H Chan; P K Li
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

6.  Production of interleukin-2 (IL-2) and expression of IL-2 receptor in patients with IgA nephropathy.

Authors:  T W Lee; M J Kim
Journal:  Korean J Intern Med       Date:  1992-01       Impact factor: 2.884

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.